查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1492384

卡比马唑市场：按适应症、最终用户、分销管道分类 - 全球预测 2024-2030

Carbimazole Market by Indication (Graves' Disease, Toxic Multinodular Goiter), End users (Clinics, Hospitals), Distribution Channel - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年卡比马唑市场规模为2.3491亿美元，预计2024年将达2.459亿美元，2030年将达3.2659亿美元，复合年增长率为4.81%。

卡比马唑是一种药物化合物，主要用于治疗甲状腺亢进（甲状腺激素分泌过多）。卡比马唑减少这些甲状腺激素的产生，从而缓解与甲状腺功能亢进相关的症状（例如心率加速、出汗过多和不明原因的体重减轻）。全球甲状腺相关疾病（包括甲状腺功能亢进）的发生率不断上升，推动了对卡比马唑等有效治疗方案的需求。此外，人们对甲状腺健康的认识不断提高，以及准确、早期检测甲状腺疾病的诊断方法不断进步，也推动了市场的成长。然而，与卡比马唑相关的副作用和安全性问题，包括粒细胞缺乏症（一种罕见但严重的白血球计数减少），可能会限制其使用。然而，对卡比马唑的遗传标记和个体反应模式的研究可能会带来更个人化和有效的治疗策略，为市场扩张开闢新的途径。

主要市场统计
基准年[2023] 2.3491亿美元
预测年份 [2024] 2.459 亿美元
预测年份 [2030] 32659万美元
复合年增长率（%） 4.81%

区域洞察

美洲尤其是北美的卡比马唑市场呈现出均衡的成长轨迹。这主要是由于美国和加拿大等国家医疗基础设施的改善以及对甲状腺疾病的认识提高。在南美洲，卡比马唑的取得情况因国家而异，医疗保健政策和经济条件影响着获取情况和消费模式。欧洲是卡比马唑的重要市场，英国、德国和法国等国甲状腺疾病盛行率较高，医疗保健系统也强大。市场受益于全面的医疗保险，有助于获得卡比马唑等药物。由于医疗成本上升和人们对甲状腺疾病的认识不断提高，亚太地区正在迅速扩张。包括中国和印度在内的人口众多的国家有大量的人受到甲状腺疾病的影响，这对这一增长至关重要。政府改善医疗基础设施和中阶富裕程度的努力催生了卡比马唑。

FPNV定位矩阵

FPNV 定位矩阵对于评估卡比马唑市场供应商的定位至关重要。此矩阵提供了对供应商的全面评估，并检验了与业务策略和产品满意度相关的关键指标。这种详细的评估使用户能够根据自己的要求做出明智的决定。根据评估，供应商被分为代表其成功程度的四个像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可对卡比马唑市场供应商的现状进行深入而详细的评估。透过仔细比较和分析供应商的贡献，您可以更深入地了解每个供应商的绩效以及他们在争夺市场占有率时面临的挑战。这些贡献包括整体收益、客户群和其他重要指标。此外，该分析还提供了对该行业竞争力的宝贵见解，包括在研究基准年期间观察到的累积、分散主导地位和合併特征等因素。有了这些详细信息，供应商可以做出更明智的决策并製定有效的策略，以在市场竞争中保持领先地位。

策略分析与建议

策略分析对于寻求在全球市场站稳脚跟的组织至关重要。对卡比马唑市场当前地位的全面评估使公司能够做出符合其长期愿望的明智决策。此关键评估涉及对组织的资源、能力和整体绩效进行彻底分析，以确定核心优势和需要改进的领域。

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 甲状腺疾病盛行率增加
      • 甲状腺健康意识和诊断的进展
      • 改善新兴经济体的医疗保健基础设施和获得照护的机会
    • 抑制因素
      • 甲状腺功能亢进症替代治疗方案的可用性
    • 机会
      • 研究遗传标记和个体反应模式
      • 开发更有效且对患者友善的卡比马唑製剂
    • 任务
      • 卡比马唑相关的副作用与安全性问题
  • 市场区隔分析
    • 适应症：卡比马唑在治疗格雷夫兹病的重要性，此病会抑制甲状腺激素的合成
    • 最终使用者：提供卡比马唑处方笺治疗甲状腺亢进的诊所的理想性
  • 市场扰动分析
  • 波特五力分析
  • 价值炼和关键路径分析
  • 价格分析
  • 技术分析
  • 专利分析
  • 贸易分析
  • 法规结构分析

第六章 卡比马唑市场的适应症

  • 格雷夫兹病
  • 毒性多结节性甲状腺肿

第七章 卡比马唑市场：依最终用户分类

  • 诊所
  • 医院

第八章卡比马唑市场：依分销管道

  • 网路药房
  • 零售药房

第九章 美洲卡比马唑市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章 亚太地区卡比马唑市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲、中东和非洲卡比马唑市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • 剪切机-Smith 推出甲硫咪唑片，学名药
    • Manx Healthcare 推出卡比马唑锭剂，扩大非专利药产品组合
  • 战略分析和建议

第13章竞争产品组合

  • 主要企业简介
  • 主要产品系列
Product Code: MRR-6B0EA0797583

[182 Pages Report] The Carbimazole Market size was estimated at USD 234.91 million in 2023 and expected to reach USD 245.90 million in 2024, at a CAGR 4.81% to reach USD 326.59 million by 2030.

The carbimazole is a medical compound primarily utilized for treating hyperthyroidism, a condition where the thyroid gland produces excessive thyroid hormones. Carbimazole functions by decreasing the production of these thyroid hormones, thereby alleviating symptoms associated with hyperthyroidism, including rapid heartbeat, excessive sweating, and unexplained weight loss. The rise in the global incidence rate of thyroid-related disorders, including hyperthyroidism, propels the need for effective treatment options such as carbimazole. Moreover, enhanced awareness about thyroid health and advancements in diagnostic approaches for accurate and early detection of thyroid disorders stimulate market growth. However, side effects and safety concerns associated with carbimazole, including agranulocytosis, a rare but serious reduction in white blood cell count, which may limit its usage. Nevertheless, research into genetic markers and individual response patterns to Carbimazole can lead to more personalized and effective treatment strategies, opening new avenues for market expansion.

KEY MARKET STATISTICS
Base Year [2023] USD 234.91 million
Estimated Year [2024] USD 245.90 million
Forecast Year [2030] USD 326.59 million
CAGR (%) 4.81%

Regional Insights

The carbimazole market in the Americas, particularly in North America, demonstrates a balanced growth trajectory. This is largely due to the well-established healthcare infrastructure and heightened awareness regarding thyroid disorders in countries including the United States and Canada. In South America, access to carbimazole varies by country, with healthcare policies and the economic landscape influencing availability and consumption patterns. Europe represents a significant market for carbimazole, attributed to a higher prevalence of thyroid disorders and robust healthcare systems in countries including the U.K., Germany, and France. The market here benefits from comprehensive healthcare coverage that facilitates access to medications like carbimazole. The Asia Pacific region witnesses a rapid expansion driven by increasing healthcare expenditures and rising awareness of thyroid disorders. Countries including China and India, with their vast populations, are pivotal to this growth, harboring a substantial number of individuals affected by thyroid issues. Government initiatives aimed at improving healthcare infrastructure, along with growing middle-class affluence, are facilitating better access to medications, including carbimazole.

Market Insights

  • Market Dynamics

The market dynamics represent an ever-changing landscape of the Carbimazole Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

    • Market Drivers
      • Increasing prevalence of thyroid disorders
      • Enhanced awareness about thyroid health and advancements in diagnostic
      • Improved healthcare infrastructure and accessibility to medicinal treatments in emerging economies
    • Market Restraints
      • Availability of alternative treatment options for hyperthyroidism
    • Market Opportunities
      • Research into genetic markers and individual response patterns
      • Development of more efficient and patient-friendly Carbimazole formulations
    • Market Challenges
      • Side effects and safety concerns associated with carbimazole
  • Market Segmentation Analysis
    • Indication: Cruciality of carbimazole in the management of Graves' Disease to inhibit the synthesis of thyroid hormones
    • End users: Ideality of clinics to offer carbimazole prescriptions in hyperthyroidism treatment
  • Market Disruption Analysis
  • Porter's Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Carbimazole Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Carbimazole Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Upsher-Smith Launches Methimazole Tablets A Generic Solution for Thyroid Disorders

Upsher-Smith has introduced generic Methimazole Tablets in 5 mg and 10 mg dosages, designed as an alternative to King Pharmaceuticals' Tapazole. These tablets are clinically recommended for individuals diagnosed with Graves' disease exhibiting hyperthyroidism, or those with toxic multinodular goiter, especially when surgical or radioactive iodine treatments are not viable options. Additionally, Methimazole serves to alleviate the symptoms of hyperthyroidism, making it a preparatory treatment before undergoing thyroidectomy or radioactive iodine therapy. [Published On: 2024-02-04]

Manx Healthcare Expands Generic Portfolio with Carbimazole Tablet Launch

Manx Healthcare proudly announces the expansion of its Generics portfolio with the introduction of Carbimazole Tablets in 5mg and 20mg dosages. Available in packs of 100 tablets, these new offerings align with the company's commitment to broadening its product range. [Published On: 2022-05-27]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Carbimazole Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Carbimazole Market, highlighting leading vendors and their innovative profiles. These include DCM Pharma Pvt. Ltd., Devlife Corporatio, Diffzene Pharmaceuticals, HCX Pharmaceuticals LLP, Healthy Inc., Manx Healthcare, Morningside Healthcare Ltd., Naiom Healthcare Private Limited, Newlife Medicare Private Limited, Omicron Pharma Private Limited, Psychocare Health Private Limited, and Steris Healthcare Pvt. Ltd..

Market Segmentation & Coverage

This research report categorizes the Carbimazole Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Indication
    • Graves' Disease
    • Toxic Multinodular Goiter
  • End users
    • Clinics
    • Hospitals
  • Distribution Channel
    • Online Pharmacies
    • Retail Pharmacies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of thyroid disorders
      • 5.1.1.2. Enhanced awareness about thyroid health and advancements in diagnostic
      • 5.1.1.3. Improved healthcare infrastructure and accessibility to medicinal treatments in emerging economies
    • 5.1.2. Restraints
      • 5.1.2.1. Availability of alternative treatment options for hyperthyroidism
    • 5.1.3. Opportunities
      • 5.1.3.1. Research into genetic markers and individual response patterns
      • 5.1.3.2. Development of more efficient and patient-friendly Carbimazole formulations
    • 5.1.4. Challenges
      • 5.1.4.1. Side effects and safety concerns associated with carbimazole
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Indication: Cruciality of carbimazole in the management of Graves' Disease to inhibit the synthesis of thyroid hormones
    • 5.2.2. End users: Ideality of clinics to offer carbimazole prescriptions in hyperthyroidism treatment
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Carbimazole Market, by Indication

  • 6.1. Introduction
  • 6.2. Graves' Disease
  • 6.3. Toxic Multinodular Goiter

7. Carbimazole Market, by End users

  • 7.1. Introduction
  • 7.2. Clinics
  • 7.3. Hospitals

8. Carbimazole Market, by Distribution Channel

  • 8.1. Introduction
  • 8.2. Online Pharmacies
  • 8.3. Retail Pharmacies

9. Americas Carbimazole Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Carbimazole Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Carbimazole Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Upsher-Smith Launches Methimazole Tablets A Generic Solution for Thyroid Disorders
    • 12.3.2. Manx Healthcare Expands Generic Portfolio with Carbimazole Tablet Launch
  • 12.4. Strategy Analysis & Recommendation

13. Competitive Portfolio

  • 13.1. Key Company Profiles
  • 13.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. CARBIMAZOLE MARKET RESEARCH PROCESS
  • FIGURE 2. CARBIMAZOLE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CARBIMAZOLE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CARBIMAZOLE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL CARBIMAZOLE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. CARBIMAZOLE MARKET DYNAMICS
  • FIGURE 7. GLOBAL CARBIMAZOLE MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL CARBIMAZOLE MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL CARBIMAZOLE MARKET SIZE, BY END USERS, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL CARBIMAZOLE MARKET SIZE, BY END USERS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS CARBIMAZOLE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS CARBIMAZOLE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES CARBIMAZOLE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES CARBIMAZOLE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC CARBIMAZOLE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC CARBIMAZOLE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CARBIMAZOLE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CARBIMAZOLE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. CARBIMAZOLE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 22. CARBIMAZOLE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CARBIMAZOLE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CARBIMAZOLE MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL CARBIMAZOLE MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL CARBIMAZOLE MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL CARBIMAZOLE MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL CARBIMAZOLE MARKET SIZE, BY GRAVES' DISEASE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL CARBIMAZOLE MARKET SIZE, BY GRAVES' DISEASE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL CARBIMAZOLE MARKET SIZE, BY TOXIC MULTINODULAR GOITER, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL CARBIMAZOLE MARKET SIZE, BY TOXIC MULTINODULAR GOITER, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL CARBIMAZOLE MARKET SIZE, BY CLINICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL CARBIMAZOLE MARKET SIZE, BY CLINICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL CARBIMAZOLE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL CARBIMAZOLE MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL CARBIMAZOLE MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL CARBIMAZOLE MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL CARBIMAZOLE MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL CARBIMAZOLE MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. AMERICAS CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 26. AMERICAS CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 27. AMERICAS CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 28. AMERICAS CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 29. AMERICAS CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 30. AMERICAS CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 31. AMERICAS CARBIMAZOLE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 32. AMERICAS CARBIMAZOLE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 33. ARGENTINA CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 34. ARGENTINA CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 35. ARGENTINA CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 36. ARGENTINA CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 37. ARGENTINA CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 38. ARGENTINA CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 39. BRAZIL CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 40. BRAZIL CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 41. BRAZIL CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 42. BRAZIL CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 43. BRAZIL CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 44. BRAZIL CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 45. CANADA CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 46. CANADA CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 47. CANADA CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 48. CANADA CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 49. CANADA CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 50. CANADA CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 51. MEXICO CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 52. MEXICO CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 53. MEXICO CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 54. MEXICO CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 55. MEXICO CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 56. MEXICO CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 57. UNITED STATES CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 58. UNITED STATES CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 59. UNITED STATES CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 60. UNITED STATES CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 61. UNITED STATES CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 62. UNITED STATES CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 63. UNITED STATES CARBIMAZOLE MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 64. UNITED STATES CARBIMAZOLE MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 67. ASIA-PACIFIC CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 68. ASIA-PACIFIC CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 69. ASIA-PACIFIC CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC CARBIMAZOLE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC CARBIMAZOLE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 73. AUSTRALIA CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 74. AUSTRALIA CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 75. AUSTRALIA CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 76. AUSTRALIA CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 77. AUSTRALIA CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 78. AUSTRALIA CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 79. CHINA CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 80. CHINA CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 81. CHINA CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 82. CHINA CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 83. CHINA CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 84. CHINA CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 85. INDIA CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 86. INDIA CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 87. INDIA CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 88. INDIA CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 89. INDIA CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 90. INDIA CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 91. INDONESIA CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 92. INDONESIA CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 93. INDONESIA CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 94. INDONESIA CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 95. INDONESIA CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 96. INDONESIA CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 97. JAPAN CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 98. JAPAN CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 99. JAPAN CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 100. JAPAN CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 101. JAPAN CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 102. JAPAN CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 103. MALAYSIA CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 104. MALAYSIA CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 105. MALAYSIA CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 106. MALAYSIA CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 107. MALAYSIA CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 108. MALAYSIA CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 109. PHILIPPINES CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 110. PHILIPPINES CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 111. PHILIPPINES CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 112. PHILIPPINES CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 113. PHILIPPINES CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 114. PHILIPPINES CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 115. SINGAPORE CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 116. SINGAPORE CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 117. SINGAPORE CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 118. SINGAPORE CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 119. SINGAPORE CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 120. SINGAPORE CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 121. SOUTH KOREA CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 122. SOUTH KOREA CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 123. SOUTH KOREA CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 124. SOUTH KOREA CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 125. SOUTH KOREA CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 126. SOUTH KOREA CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 127. TAIWAN CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 128. TAIWAN CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 129. TAIWAN CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 130. TAIWAN CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 131. TAIWAN CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 132. TAIWAN CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 133. THAILAND CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 134. THAILAND CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 135. THAILAND CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 136. THAILAND CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 137. THAILAND CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 138. THAILAND CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 139. VIETNAM CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 140. VIETNAM CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 141. VIETNAM CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 142. VIETNAM CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 143. VIETNAM CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 144. VIETNAM CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 145. EUROPE, MIDDLE EAST & AFRICA CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA CARBIMAZOLE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA CARBIMAZOLE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 153. DENMARK CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 154. DENMARK CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 155. DENMARK CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 156. DENMARK CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 157. DENMARK CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 158. DENMARK CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 159. EGYPT CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 160. EGYPT CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 161. EGYPT CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 162. EGYPT CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 163. EGYPT CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 164. EGYPT CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 165. FINLAND CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 166. FINLAND CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 167. FINLAND CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 168. FINLAND CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 169. FINLAND CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 170. FINLAND CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 171. FRANCE CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 172. FRANCE CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 173. FRANCE CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 174. FRANCE CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 175. FRANCE CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 176. FRANCE CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 177. GERMANY CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 178. GERMANY CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 179. GERMANY CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 180. GERMANY CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 181. GERMANY CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 182. GERMANY CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 183. ISRAEL CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 184. ISRAEL CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 185. ISRAEL CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 186. ISRAEL CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 187. ISRAEL CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 188. ISRAEL CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 189. ITALY CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 190. ITALY CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 191. ITALY CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 192. ITALY CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 193. ITALY CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 194. ITALY CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 195. NETHERLANDS CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 196. NETHERLANDS CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 197. NETHERLANDS CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 198. NETHERLANDS CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 199. NETHERLANDS CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 200. NETHERLANDS CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 201. NIGERIA CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 202. NIGERIA CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 203. NIGERIA CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 204. NIGERIA CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 205. NIGERIA CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 206. NIGERIA CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 207. NORWAY CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 208. NORWAY CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 209. NORWAY CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 210. NORWAY CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 211. NORWAY CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 212. NORWAY CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 213. POLAND CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 214. POLAND CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 215. POLAND CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 216. POLAND CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 217. POLAND CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 218. POLAND CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 219. QATAR CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 220. QATAR CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 221. QATAR CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 222. QATAR CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 223. QATAR CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 224. QATAR CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 225. RUSSIA CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 226. RUSSIA CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 227. RUSSIA CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 228. RUSSIA CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 229. RUSSIA CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 230. RUSSIA CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 231. SAUDI ARABIA CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 232. SAUDI ARABIA CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 233. SAUDI ARABIA CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 234. SAUDI ARABIA CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 235. SAUDI ARABIA CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 236. SAUDI ARABIA CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 237. SOUTH AFRICA CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 238. SOUTH AFRICA CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 239. SOUTH AFRICA CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 240. SOUTH AFRICA CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 241. SOUTH AFRICA CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 242. SOUTH AFRICA CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 243. SPAIN CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 244. SPAIN CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 245. SPAIN CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 246. SPAIN CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 247. SPAIN CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 248. SPAIN CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 249. SWEDEN CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 250. SWEDEN CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 251. SWEDEN CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 252. SWEDEN CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 253. SWEDEN CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 254. SWEDEN CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 255. SWITZERLAND CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 256. SWITZERLAND CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 257. SWITZERLAND CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 258. SWITZERLAND CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 259. SWITZERLAND CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 260. SWITZERLAND CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 261. TURKEY CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 262. TURKEY CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 263. TURKEY CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 264. TURKEY CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 265. TURKEY CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 266. TURKEY CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 267. UNITED ARAB EMIRATES CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 268. UNITED ARAB EMIRATES CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 269. UNITED ARAB EMIRATES CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 270. UNITED ARAB EMIRATES CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 271. UNITED ARAB EMIRATES CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 272. UNITED ARAB EMIRATES CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 273. UNITED KINGDOM CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 274. UNITED KINGDOM CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 275. UNITED KINGDOM CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 276. UNITED KINGDOM CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 277. UNITED KINGDOM CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 278. UNITED KINGDOM CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 279. CARBIMAZOLE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 280. CARBIMAZOLE MARKET, FPNV POSITIONING MATRIX, 2023